Compare Amgen, Inc. (AMGN) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Roblox Corp — how do they compare? Amgen, Inc. trades at $362.14 (market cap $196.12B), while Roblox Corp trades at $55.3 (market cap $39.63B). The key difference: Amgen, Inc. is far larger — about 4.9× Roblox Corp's market cap, and Amgen, Inc. pays a 2.77% dividend while Roblox Corp pays none. Which is the better fit depends on your goals.
| AMGN | RBLX | |
|---|---|---|
Market Cap | $196.12B | $39.63B |
Sector | Health | Media |
52-Week High | $388.16 | $141.56 |
52-Week Low | $271.18 | $41.30 |
Enterprise Value | $241.41B | $38.22B |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Roblox (RBLX) trades at $55.35, down 1.9% on the day, amid a bullish technical signal and strong analyst support. The stock shows consistent revenue growth, with 2025 revenue reaching $4.89 billion, though it remains unprofitable with a net income margin of -20.69%. Recent earnings have beaten expectations, but the company faces headwinds from a securities class action lawsuit related to age-verification disclosures. Operating cash flow improved to $1.8 billion in 2025, signaling healthy core business operations despite ongoing losses.
The outlook for RBLX is mixed; robust user monetization and revenue growth present upside potential, supported by a consensus price target of $64.07. However, persistent losses, high valuation multiples like a P/B of 91.73, and legal risks weigh on investor confidence. The stock's trajectory hinges on achieving profitability and navigating regulatory scrutiny, making it a high-risk, growth-oriented play.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
